{
  "company_number": "10436822",
  "name": "Lyrus Life Sciences Limited",
  "url": "/company/10436822",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2016-10-19",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "74909",
      "description": "Other professional, scientific and technical activities n.e.c.",
      "section": "M",
      "section_name": "Professional, scientific and technical activities",
      "url": "/sic/74909"
    }
  ],
  "registered_address": {
    "id": 652226,
    "url": "/address/652226",
    "line1": "C/O THAKUR-CHABERT",
    "line2": "7A VINE STREET",
    "post_town": "UXBRIDGE",
    "county": "",
    "country": "ENGLAND",
    "postcode": "UB8 1QE"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10436822",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-07-31",
    "last_made_up": "2025-10-31",
    "category": "SMALL",
    "filings": [
      {
        "url": "/company/10436822/accounts/2025-10-31",
        "made_up_date": "2025-10-31",
        "period_start": "2024-11-01",
        "period_end": "2025-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "641960.00",
        "debtors": "395924.00",
        "cash_bank_in_hand": "28404.00",
        "current_assets": "424328.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-236899.00",
        "total_assets_less_current_liabilities": "405061.00",
        "net_assets_liabilities": "405061.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "584502.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "24165.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2026.zip"
      },
      {
        "url": "/company/10436822/accounts/2024-10-31",
        "made_up_date": "2024-10-31",
        "period_start": "2023-11-01",
        "period_end": "2024-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "605983.00",
        "debtors": "260121.00",
        "cash_bank_in_hand": "29240.00",
        "current_assets": "289361.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-225087.00",
        "total_assets_less_current_liabilities": "380896.00",
        "net_assets_liabilities": "380896.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "584502.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "-105543.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2025.zip"
      },
      {
        "url": "/company/10436822/accounts/2023-10-31",
        "made_up_date": "2023-10-31",
        "period_start": "2023-10-31",
        "period_end": "2023-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "430487.00",
        "debtors": "330855.00",
        "cash_bank_in_hand": "38522.00",
        "current_assets": "369377.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "55952.00",
        "total_assets_less_current_liabilities": "486439.00",
        "net_assets_liabilities": "-98061.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2024.zip"
      },
      {
        "url": "/company/10436822/accounts/2022-10-31",
        "made_up_date": "2022-10-31",
        "period_start": "2022-10-31",
        "period_end": "2022-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "398498.00",
        "debtors": "50614.00",
        "cash_bank_in_hand": "16359.00",
        "current_assets": "66973.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "867.00",
        "total_assets_less_current_liabilities": "399365.00",
        "net_assets_liabilities": "-109135.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2023.zip"
      },
      {
        "url": "/company/10436822/accounts/2021-10-31",
        "made_up_date": "2021-10-31",
        "period_start": "2021-10-31",
        "period_end": "2021-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "334906.00",
        "debtors": "1243.00",
        "cash_bank_in_hand": "7628.00",
        "current_assets": "8871.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-29767.00",
        "total_assets_less_current_liabilities": "305139.00",
        "net_assets_liabilities": "-64861.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2022.zip"
      },
      {
        "url": "/company/10436822/accounts/2019-10-31",
        "made_up_date": "2019-10-31",
        "period_start": "2019-10-31",
        "period_end": "2019-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "2.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2020.zip"
      },
      {
        "url": "/company/10436822/accounts/2018-10-31",
        "made_up_date": "2018-10-31",
        "period_start": "2018-10-31",
        "period_end": "2018-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "2.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2019.zip"
      },
      {
        "url": "/company/10436822/accounts/2017-10-31",
        "made_up_date": "2017-10-31",
        "period_start": "2017-10-31",
        "period_end": "2017-10-31",
        "entity_name": "Lyrus Life Sciences Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "2.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2017.zip"
      }
    ],
    "pdf_only_filings": [
      {
        "made_up_date": "2020-10-31",
        "filing_date": "2021-08-08",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-small",
        "paper_filed": true,
        "pdf_url": "/company/10436822/accounts/2020-10-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10436822/filing-history/MzMwOTU3MTIyOGFkaXF6a2N4/document?format=pdf&download=0"
      }
    ],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10436822/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-02-16",
    "last_made_up": "2026-02-02"
  },
  "officers": [],
  "psc": [
    {
      "name": "Hemanth Kumar Bothra",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/1900853",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2016-10-19",
      "ceased_on": null,
      "nationality": "Indian",
      "country_of_residence": "India",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-02T05:26:26.711035+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}